Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

TARO

  • FDA Approval
  • April 12, 2024, 08:59 UTC
  • 36
  • 0 comments

FDA approve ADAPALENE; BENZOYL PEROXIDE

Comment Full text

ABLYNX NV

  • FDA Approval
  • April 12, 2024, 08:59 UTC
  • 40
  • 0 comments

FDA approve CAPLACIZUMAB-YHDP

Comment Full text

MYLAN PHARMS INC

  • FDA Approval
  • April 12, 2024, 08:59 UTC
  • 38
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; VALSARTAN

Comment Full text

ACTELION

  • FDA Approval
  • April 12, 2024, 08:59 UTC
  • 36
  • 0 comments

FDA approve MACITENTAN

Comment Full text

TEVA PHARMS USA INC

  • FDA Approval
  • April 12, 2024, 08:59 UTC
  • 38
  • 0 comments

FDA approve PLERIXAFOR

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • April 12, 2024, 08:59 UTC
  • 42
  • 0 comments

FDA approve SEVELAMER CARBONATE

Comment Full text

SAGENT PHARMS INC

  • FDA Approval
  • April 12, 2024, 08:59 UTC
  • 40
  • 0 comments

FDA approve PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 12, 2024, 08:59 UTC
  • 37
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 12, 2024, 08:59 UTC
  • 40
  • 0 comments

FDA approve BETAMETHASONE DIPROPIONATE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • April 12, 2024, 08:59 UTC
  • 35
  • 0 comments

FDA approve LISINOPRIL

Comment Full text
  • Previous
  • 479
  • 480
  • 481
  • 482
  • 483
  • Next

Search

News categories

  • Technical Exchange News(11745)
  • Event(4121)
  • SEC News(233052)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(142438)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin